Target intelligence / Profile preview

Novel transcript, sense intronic to protocadherin 7 (null)

Target
null
Molecular classification
Other
01

Overview

ENSG00000303168 refers to a novel transcript characterized as *sense intronic* to the PCDH7 gene, annotated as a long non-coding RNA (lncRNA)[3]. It does not encode a protein or function as a receptor, enzyme, transporter, or canonical therapeutic target. It is distinct from PCDH7 itself, which is an established receptor-like transmembrane protein involved in cancer and physiological cell adhesion[1][4][2][6]. "Novel transcript, sense intronic to PCDH7" is not a commonly accepted target name; this entity is primarily described in genomic databases as an uncharacterized RNA gene located within an intron of PCDH7[3]. There is no public evidence for its biological function, disease role, or drug interactions, nor is it regarded as a therapeutic target. The entry is likely subject to nomenclature issues or annotation ambiguity, and the typical conventions (such as canonical name, protein function, or disease relevance) do not apply. To study therapeutic targets related to this locus, focus should be on the parent gene PCDH7 (“Protocadherin 7”), which has established roles in cancer[1][4]. **Note:** If you intended to query the canonical protein-coding gene *PCDH7* (“Protocadherin 7”), that is a receptor-like membrane protein with clear biological and disease relevance; ENSG00000303168 is not that entity[3].

Other names
Sense intronic transcript to PCDH7ENSG00000303168
02

Mechanism of action

null

03

Biological functions

Unknown
04

Disease associations

Unknown

Beyond the preview

Go deeper on Novel transcript, sense intronic to protocadherin 7 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to protocadherin 7 (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call